Assessing the asymptomatic reservoir and dihydroartemisinin-piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum

Malaria Journal

Volumn 15, Issue 1, 2016, Pages

  Falq, Grégoire ^a   Van Den Bergh, Rafael ^b   De Smet, Martin ^a   Etienne, William ^a   Nguon, Chea ^c   Rekol, Huy ^c   Imwong, Mallika ^d   Dondorp, Arjen ^d   Kindermans, Jean Marie ^a  

^a MÉDECINS SANS FRONTIÈRES   (Belgium)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

^c Centre for Parasitology Entomology and Malaria Control   (Cambodia)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Artemisinin resistance; Cambodia; Epidemiology; k13 propeller; Malaria; Plasmodium falciparum; Polymerase chain reaction

Indexed keywords

ARTEMISININ; DIHYDROARTEMISININ PLUS PIPERAQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DIHYDROARTEMISININ; PIPERAQUINE; QUINOLINE DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; CAMBODIA; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG EFFICACY; FEMALE; GENE; GENE MUTATION; GENETIC SCREENING; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HUMAN; INCIDENCE; INFANT; K13 GENE; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; NONHUMAN; OUTCOME ASSESSMENT; PARASITE IDENTIFICATION; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; AGED; ASYMPTOMATIC DISEASES; DRUG EFFECTS; DRUG RESISTANCE; ISOLATION AND PURIFICATION; MALARIA, FALCIPARUM; MIDDLE AGED; NEWBORN; PARASITOLOGY; PRESCHOOL CHILD; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIMALARIALS; ARTEMISININS; ASYMPTOMATIC DISEASES; CAMBODIA; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PLASMODIUM FALCIPARUM; PREVALENCE; QUINOLINES; REAL-TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84984922328     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-016-1487-z     Document Type: Article

References (24)

1. WHO. World malaria report. Geneva: World Health Organization; 2013. http://www.who.int/malaria/publications/world-malaria-report-2013/en/. Accessed 23 Aug 2016.
2. WHO. Global plan for artemisinin resistance containment. Geneva: World Health Organization; 2011. http://www.who.int/malaria/publications/atoz/artemisinin-resistance-containment-2011.pdf. Accessed 23 Aug 2016.
3. Maude RJ, Pontavornpinyo W, Saralamba S, Aguas R, Yeung S, Dondorp AM, et al. The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia. Malar J. 2009;8:31.
4. Okell LC, Griffin JT, Kleinschmidt I, Hollingsworth TD, Churcher TS, White MJ, et al. The potential contribution of mass treatment to the control of Plasmodium falciparum malaria. PLoS One. 2011;6:e20179.
5. Stresman G, Kobayashi T, Kamanga A, Thuma PE, Mharakurwa S, Moss WJ, et al. Malaria research challenges in low prevalence settings. Malar J. 2012;11:353.
6. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359:2619-20.
7. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455-67.
8. Amaratunga C, Sreng S, Suon S, Phelps ES, Stepniewska K, Lim P, et al. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect Dis. 2012;12:851-8.
9. WHO. Global report on antimalarial drug efficacy and drug resistance 2000-2010. Geneva: World Health Organization; 2010.
10. WHO. Artemisinin and artemisinin-based combination therapy resistance. Geneva: World Health Organization; 2016.
11. Imwong M, Hanchana S, Malleret B, Renia L, Day NPJ, Dondorp A, et al. High-throughput ultrasensitive molecular techniques for quantifying low-density malaria parasitemias. J Clin Microbiol. 2014;52:3303-9.
12. Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A-C, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50-5.
13. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411-23.
14. Manske M, Miotto O, Campino S, Auburn S, Almagro-Garcia J, Maslen G, et al. Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature. 2012;487:375-9.
15. WHO. Disease surveillance for malaria control: an operation manual. Geneva: World Health Organization; 2012.
16. Deville JC, Sarndal CE, Sautory O. Generalized raking procedures in survey sampling. J Am Stat Assoc. 1993;88:1013-20.
17. Rao JNK, Scott AJ. On Chi squared tests for multiway contingency tables with cell proportions estimated from survey data. Ann Stat. 1984;12:46-60.
18. Bosman P, Stassijns J, Nackers F, Canier L, Kim N, Khim S, et al. Plasmodium prevalence and artemisinin-resistant falciparum malaria in Preah Vihear Province, Cambodia: a cross-sectional population-based study. Malar J. 2014;13:394.
19. Tripura R, Peto TJ, Chalk J, Lee SJ, Sirithiranont P, Nguon C, et al. Persistent Plasmodium falciparum and Plasmodium vivax infections in a western Cambodian population: implications for prevention, treatment and elimination strategies. Malar J. 2016;15:181.
20. Maude RJ, Socheat D, Nguon C, Saroth P, Dara P, Li G, et al. Optimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance. PLoS One. 2012;7:e37166.
21. Spring MD, Lin JT, Manning JE, Vanachayangkul P, Somethy S, Bun R, et al. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. Lancet Infect Dis. 2015;15:683-91.
22. Chaorattanakawee S, Saunders DL, Sea D, Chanarat N, Yingyuen K, Sundrakes S, et al. Ex vivo drug susceptibility testing and molecular profiling of clinical Plasmodium falciparum isolates from Cambodia from 2008 to 2013 suggest emerging piperaquine resistance. Antimicrob Agents Chemother. 2015;59:4631-43.
23. Leang R, Taylor WRJ, Bouth DM, Song L, Tarning J, Char MC, et al. Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in Western Cambodia: dihydroartemisinin-piperaquine open-label multicenter clinical assessment. Antimicrob Agents Chemother. 2015;59:4719-26.
24. Amaratunga C, Lim P, Suon S, Sreng S, Mao S, Sopha C, et al. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect Dis. 2016;3:357-65.